Successful 4th International CytoSorb Users Meeting 2017
The day before the start of the 37th ISICEM, the 4th International Users Meeting brought together 120 CytoSorb users and other interested parties from a total of 22 countries. The international faculty shared an update on the latest scientific findings, recent study results and case series in different patient groups, followed by a podium discussion.
Between the lectures the participants could benefit from the possibility to exchange their experiences made with the CytoSorb therapy. To date, CytoSorb therapy has been used in more than 20,000 human treatments in more than 450 hospitals around the world.
Cytosorbents Europe GmbH, headquartered in Berlin, is a wholly owned subsidiary of CytoSorbents Corporation of Monmouth Junction, New Jersey, USA, where the CytoSorb product is manufactured. CytoSorb is the company’s flagship product, backed by more than 30 patent families.
Welcome: 6th International CytoSorb Users` Meeting
Subscribe to our newsletter now!
Get access to the CytoSorbents Community Area. The current newsletter contains a direct link to the CytoSorbents Community Area.